84 related articles for article (PubMed ID: 30511892)
1. SYCP2 expression is a novel prognostic biomarker in luminal A/B breast cancer.
Wu C; Tuo Y
Future Oncol; 2019 Mar; 15(8):817-826. PubMed ID: 30511892
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of MUC1 predicts poor prognosis in patients with breast cancer.
Jing X; Liang H; Hao C; Yang X; Cui X
Oncol Rep; 2019 Feb; 41(2):801-810. PubMed ID: 30483806
[TBL] [Abstract][Full Text] [Related]
3. High NUP43 expression might independently predict poor overall survival in luminal A and in HER2+ breast cancer.
Tian C; Zhou S; Yi C
Future Oncol; 2018 Jun; 14(15):1431-1442. PubMed ID: 29402145
[TBL] [Abstract][Full Text] [Related]
4. Identification of methylation sites and signature genes with prognostic value for luminal breast cancer.
Xiao B; Chen L; Ke Y; Hang J; Cao L; Zhang R; Zhang W; Liao Y; Gao Y; Chen J; Li L; Hao W; Sun Z; Li L
BMC Cancer; 2018 Apr; 18(1):405. PubMed ID: 29642861
[TBL] [Abstract][Full Text] [Related]
5. Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.
Netanely D; Avraham A; Ben-Baruch A; Evron E; Shamir R
Breast Cancer Res; 2016 Jul; 18(1):74. PubMed ID: 27386846
[TBL] [Abstract][Full Text] [Related]
6. Survival differences of CIMP subtypes integrated with CNA information in human breast cancer.
Wang H; Yan W; Zhang S; Gu Y; Wang Y; Wei Y; Liu H; Wang F; Wu Q; Zhang Y
Oncotarget; 2017 Jul; 8(30):48807-48819. PubMed ID: 28415743
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatics analysis of prognostic value of
Chen WX; Cheng L; Xu LY; Qian Q; Zhu YL
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30837324
[No Abstract] [Full Text] [Related]
8. Epigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple negative breast cancers.
Ward AK; Mellor P; Smith SE; Kendall S; Just NA; Vizeacoumar FS; Sarker S; Phillips Z; Alvi R; Saxena A; Vizeacoumar FJ; Carlsen SA; Anderson DH
Breast Cancer Res; 2016 Jan; 18(1):12. PubMed ID: 26810754
[TBL] [Abstract][Full Text] [Related]
9. CHST11 gene expression and DNA methylation in breast cancer.
Herman D; Leakey TI; Behrens A; Yao-Borengasser A; Cooney CA; Jousheghany F; Phanavanh B; Siegel ER; Safar AM; Korourian S; Kieber-Emmons T; Monzavi-Karbassi B
Int J Oncol; 2015 Mar; 46(3):1243-51. PubMed ID: 25586191
[TBL] [Abstract][Full Text] [Related]
10. FGFR1 is an adverse outcome indicator for luminal A breast cancers.
Shi YJ; Tsang JY; Ni YB; Chan SK; Chan KF; Tse GM
Oncotarget; 2016 Jan; 7(4):5063-73. PubMed ID: 26673008
[TBL] [Abstract][Full Text] [Related]
11. Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013.
Ehinger A; Malmström P; Bendahl PO; Elston CW; Falck AK; Forsare C; Grabau D; Rydén L; Stål O; Fernö M;
Acta Oncol; 2017 Jan; 56(1):68-74. PubMed ID: 27762648
[TBL] [Abstract][Full Text] [Related]
12. High expression of long non-coding RNA MALAT1 in breast cancer is associated with poor relapse-free survival.
Wang Z; Katsaros D; Biglia N; Shen Y; Fu Y; Loo LWM; Jia W; Obata Y; Yu H
Breast Cancer Res Treat; 2018 Sep; 171(2):261-271. PubMed ID: 29845475
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation mediated silencing of microRNA-874 is a promising diagnosis and prognostic marker in breast cancer.
Zhang L; Yan DL; Yang F; Wang DD; Chen X; Wu JZ; Tang JH; Xia WJ
Oncotarget; 2017 Jul; 8(28):45496-45505. PubMed ID: 28525377
[TBL] [Abstract][Full Text] [Related]
14. The prognostic significance of topoisomerase II alpha protein in early stage luminal breast cancer.
An X; Xu F; Luo R; Zheng Q; Lu J; Yang Y; Qin T; Yuan Z; Shi Y; Jiang W; Wang S
BMC Cancer; 2018 Mar; 18(1):331. PubMed ID: 29587760
[TBL] [Abstract][Full Text] [Related]
15. Association of uPA and PAI-1 tumor levels and 4G/5G variants of PAI-1 gene with disease outcome in luminal HER2-negative node-negative breast cancer patients treated with adjuvant endocrine therapy.
Jevrić M; Matić IZ; Krivokuća A; Đorđić Crnogorac M; Besu I; Damjanović A; Branković-Magić M; Milovanović Z; Gavrilović D; Susnjar S; Kisić Tepavčević D; Stanojković T
BMC Cancer; 2019 Jan; 19(1):71. PubMed ID: 30646864
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of the deregulated kallikrein-related peptidase 8 mRNA expression in breast cancer: a novel independent indicator of disease-free survival.
Michaelidou K; Ardavanis A; Scorilas A
Breast Cancer Res Treat; 2015 Jul; 152(2):323-36. PubMed ID: 26099606
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the relevance between molecular subtypes and efficacy of neoadjuvant chemotherapy in breast cancer as well as its prognostic factors.
Li F; Ma L; Geng C; Liu C; Deng H; Yue M; Ding Y; Wang X; Liu Y
Pathol Res Pract; 2018 Aug; 214(8):1166-1172. PubMed ID: 29945816
[TBL] [Abstract][Full Text] [Related]
18. Laboratory validation of formal concept analysis of the methylation status of microarray-detected genes in primary breast cancer.
Kassim SK; Shehata HH; Abou-Alhussein MM; Sallam MM; Amin II
Tumour Biol; 2017 Jun; 39(6):1010428317698390. PubMed ID: 28618938
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation mediated silencing of microRNA-145 is a potential prognostic marker in patients with lung adenocarcinoma.
Xia W; Chen Q; Wang J; Mao Q; Dong G; Shi R; Zheng Y; Xu L; Jiang F
Sci Rep; 2015 Nov; 5():16901. PubMed ID: 26582602
[TBL] [Abstract][Full Text] [Related]
20. Expression and prognostic values of ARID family members in breast cancer.
Zhang J; Hou S; You Z; Li G; Xu S; Li X; Zhang X; Lei B; Pang D
Aging (Albany NY); 2021 Feb; 13(4):5621-5637. PubMed ID: 33592583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]